MMedication Read More Prescription Blood Thinner Recalled Nationwide, FDA WarnsAugust 3, 2026 “Hearst Magazines and Yahoo may earn commission or revenue on some items through these links.” If you take…
MMedication Read More Medicines, Misleading Ads On Tukaram Mundhe’s Radar? Maharashtra FDA Chief Says…August 1, 2026 Maharashtra Food and Drug Administration Commissioner Tukaram Mundhe has said the agency is expanding its enforcement beyond food…
MMedication Read More FDA warns on compounded GLP-1 weight loss drugsJuly 29, 2026 The FDA and doctors are warning patients away from compounded versions of popular weight loss drugs, citing safety…
MMedication Read More FDA approves Tylenol with Naproxen OTC comboJuly 28, 2026 (Gray News) – The first fixed-dose combination of acetaminophen (Tylenol) and naproxen sodium was approved by the FDA.…
HHealthcare Read More Vaccines Are Safe. A Worrisome Portion Of Our Generic Drugs Are NotJuly 27, 2026 WASHINGTON, DC – APRIL 16: U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. speaks at…
MMedication Read More FDA Recalls Thyroid Meds Across the USJuly 26, 2026 Thyroid patients are being urged to look closely at their pills after a batch of a widely…
MMedication Read More Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pillsJuly 25, 2026 (Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…
MMedication Read More Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pillsJuly 25, 2026 (Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…
MMedication Read More Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pills | Local NewsJuly 24, 2026 LOUISVILLE, Ky. (WDRB/Gray Media) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another…
MMedication Read More Revolution Medicines’ New Drug Application for Daraxonrasib Accepted for Review by U.S. FDA for Previously Treated Metastatic Pancreatic CancerJuly 24, 2026 Revolution Medicines, Inc. REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
MMedication Read More Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pillsJuly 24, 2026 (Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…
MMedication Read More An FDA Panel Just Endorsed These Unproven PeptidesJuly 24, 2026 Peptides are inching closer to the mainstream. A panel of experts on Thursday narrowly recommended that the Food…